Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$225.07 - $246.17 $33,535 - $36,679
149 Added 17.95%
979 $228,000
Q1 2024

May 07, 2024

BUY
$233.45 - $247.73 $193,763 - $205,615
830 New
830 $205,000
Q3 2023

Oct 24, 2023

BUY
$254.9 - $283.59 $53,783 - $59,837
211 Added 22.07%
1,167 $301,000
Q2 2023

Aug 02, 2023

BUY
$238.39 - $265.32 $17,164 - $19,103
72 Added 8.14%
956 $252,000
Q1 2023

May 03, 2023

BUY
$229.71 - $259.35 $19,984 - $22,563
87 Added 10.92%
884 $218,000
Q4 2022

Feb 01, 2023

SELL
$218.29 - $256.91 $56,755 - $66,796
-260 Reduced 24.6%
797 $202,000
Q3 2022

Nov 02, 2022

SELL
$51.03 - $264.23 $1,735 - $8,983
-34 Reduced 3.12%
1,057 $236,000
Q2 2022

Aug 04, 2022

BUY
$234.74 - $275.42 $63,379 - $74,363
270 Added 32.89%
1,091 $269,000
Q1 2022

May 05, 2022

BUY
$243.64 - $270.48 $200,028 - $222,064
821 New
821 $213,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.